Financials
- Financial year
- 2025
- Turnover
- €6.1m
- Profit
- €56,097
- Solvency
- 70.3%
Turnover▲ 3.1%
Net result
20202025
Bio -X Diagnostics
ActiveSummary
Bio -X Diagnostics has been active since 1990 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3.6m and a net result of €56,097. Equity remains stable across the filed financial years (±0.9% per year). Its solvency ranks better than 77% of 6,141 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
Activity
Wholesale of industrial chemicals
NACE 46851Wholesale of pharmaceutical and medical goods NACE 46460
2nd largest company by equity in Rochefort, Wholesale and retail trade sector1 site
Size
€6.1mturnover 2025
- Staff
- 24.6 FTE
- Equity
- €3.6m
- Profit
- €56,097
Structure
- Parent
- HOLDING MAESTRO · 51.02%
- Holdings
- 1
Auditor: RSM Reviseurs d'Entreprises-Bedrijfsrevisoren2025 accounts 1 day early2 of 6 deeds summarised
Why 89raises riskLiquidity: current ratio 1.65, cash €136,803, halvedSize: turnover €6.1m, 24.6 FTE, total assets €5.2mlowers riskFounded in 1990Equity €3.6m (70.3% of total assets)Show the evidence
Checked score
Score 2025
89
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 55% of its sector peers (NACE 46, small)
Financial strength · tick = 2024
Strong
Solvency
95+2
equity 70.3% of total assets
Liquidity
41-9
short-term debt 29.1% · cash 2.6%
Profitability
61-5
return on assets 1.1%
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.1%
12-2024: 0.1%● unchanged vs 11-2024
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.2%▲ +0.1 percentage points vs 03-2025highest value
05-2025: 0.1%▼ -0.1 percentage points vs 04-2025
06-2025: 0.1%● unchanged vs 05-2025
07-2025: 0.1%● unchanged vs 06-2025
08-2025: 0.1%● unchanged vs 07-2025
09-2025: 0.1%● unchanged vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025lowest value
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.2%▲ +0.1 percentage points vs 03-2026
05-2026: 0.2%● unchanged vs 04-2026
06-2026: 0.2%● unchanged vs 05-2026
07-2026: 0.2%● unchanged vs 06-2026
08-2026: 0.2%● unchanged vs 07-2026
09-2026: 0.2%● unchanged vs 08-2026
10-2026: 0.2%● unchanged vs 09-2026
Credit of up to €320,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.65, compared with 1.89 in 2024, above the usual 1.5; short-term debt: 29.1% and cash: 2.6% of total assets), and 29.7% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, small): better than 79% on solvency, 47% on liquidity, 47% on profitability and 48% on growth.
The bankruptcy probability was computed on 25-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-08-2025 was due by 31-03-2026 and was filed on 30-03-2026, 1 day ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
1 day early
2024
24 days late
2023
10 days early
2022
8 days early
2021
10 days early
2020
on the day
2019
16 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 3 days before the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 31-08-2026 is due by 31-03-2027. Nothing is late today. The company usually files around 23 March (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
31-08-2026 year end26-10-2026 today31-03-2027 deadline
- Annual accounts filedfinancial year 2025 · full…
- Resignation: Béatrice BLANCHARD (director)Permanent representatives: Philippe HIVOREL, Julien…
- Annual accounts filedfinancial year 2024 · full…
Key points
- Caution: Result fell in 2025from €174,667 to €56,097 ▼ 67.9% View
- Positive: 2nd largest company by equity in Rochefort, Wholesale and retail trade sectorin the Checked rankings No. 2 View
- Caution: A director leftlatest change 07-01-2026 · 1 in office 1 left View
- Controlled by HOLDING MAESTROthe company in turn controls 1 companies 51.02% View
- Positive: 7 profitable years in a rowprofit 2025: €56,097 7 years View
By topic
Board & ownership
- Board
- 1 member
- Parent
- HOLDING MAESTRO · 51.02%
- Auditor
- RSM Reviseurs d'Entreprises-Bedrijfsrevisoren
- VAN DAM Hendrik Christiaan BarendDirector
Network & group
- Subsidiaries
- 1
1 subsidiary
Timeline
- Events
- 32
- Since
- 1999
- Next accounts
- by 31-03-2027
- 27-11-2024Resignation: LE GUENNEC Jean Joseph Marie (director)
- 21-03-2024Annual accounts filed
- 23-03-2023Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Public limited company
- Activity
- Wholesale of industrial chemicalsNACE 46851
- Founded
- 23-04-1990
- Year ends
- 31-08
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 16
- Annual meeting
- Fourth Thursday of November at 17:00
- Purpose
- “Toute opération se rattachant directement ou indirectement à la fabrication,la…” (deed in French)
Key facts about Bio -X Diagnostics
- What is the company number of Bio -X Diagnostics?
- 0441.580.721. In Belgium the VAT number is the company number with BE in front: BE 0441.580.721.
- Where is Bio -X Diagnostics based?
- The registered office is at Rue de la Calestienne 38, 5580 Rochefort.Company details
- What does Bio -X Diagnostics do?
- According to the KBO register, the main activity is wholesale of industrial chemicals (NACE 46851).
- What is the legal form of Bio -X Diagnostics?
- Public limited company (NV).
- When was Bio -X Diagnostics founded?
- On 23-04-1990.
- Is Bio -X Diagnostics still active?
- Yes, Bio -X Diagnostics is an active enterprise in the KBO register.
- How many employees does Bio -X Diagnostics have?
- On average 24.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of Bio -X Diagnostics?
- €6.1m in financial year 2025, according to the filed annual accounts.
- Is Bio -X Diagnostics profitable?
- In financial year 2025, Bio -X Diagnostics made a profit of €56,097.
- Where can I find the annual accounts of Bio -X Diagnostics?
- Bio -X Diagnostics filed 28 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Bio -X Diagnostics due?
- By 31-03-2027, for financial year 2026.Timeline
Companies related to Bio -X Diagnostics
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.